Venrock, a premiere venture capital firm originally established as the venture arm of the Rockefeller family, today announced that Bruce Pasternack joined as an operating partner. In his role, Pasternack will support companies in the firm’s energy portfolio and provide alignment with energy policy and administration in Washington.
Prior to joining Venrock, Pasternack was a venture partner with CMEA Capital. During his career, he spent nearly 30 years at Booz Allen Hamilton, most recently as a senior vice president and managing partner of its San Francisco office. During his tenure there, he led the company’s Organization and Strategic Leadership Practice and its Energy, Chemicals, and Pharmaceuticals Practice.
Prior to that, Pasternack served in a spectrum of roles for the US government. He was the senior energy policy official in the Executive Branch while at the Federal Energy Administration, the predecessor to the Department of Energy. He also served on the White House Energy Resources Council. Additionally, he was on the staff of the Council on Environmental Quality in the Executive Office of the President of the United States.
Currently, Pasternack serves on the boards of Codexis, Quantum and Symyx, as well as the American Council on Renewable Energy (ACORE). He has also served as President and CEO of Special Olympics International and has co-authored two business books, The Centerless Corporation and Results. Pasternack holds an M.S.E. in systems engineering and operations research from the University of Pennsylvania and a B.E. in mechanical engineering from The Cooper Union, where he serves on the board of trustees.
“Bruce brings enormous intellectual capital and experience in management consulting to Venrock and its portfolio companies,” said Ray Rothrock, partner, Venrock. “In addition, with both increased federal support and regulations impacting the energy industry, Bruce’s first-hand experience in Washington is a real asset.”
Venrock is a premier venture capital firm with offices in Palo Alto, New York, Cambridge, MA and Israel. Originally established as the venture capital arm of the Rockefeller family, Venrock continues the eight-decade tradition of partnering with entrepreneurs to establish successful, enduring companies. Having invested $2.5 billion in nearly 450 companies resulting in more than 120 IPOs in 41 years, Venrock’s investment returns place it among the top tier venture capital firms that have achieved consistently superior performance. With a primary focus on technology, healthcare, and energy portfolio companies have included Adify, Adnexus Therapeutics, Apple Computer, athenahealth, Centocor, Check Point Software, DoubleClick, Gilead Sciences, Idec Pharmaceuticals, Illumina, Intel, Ironwood, Millennium Pharmaceuticals, Sirna Therapeutics, StrataCom, and Vontu. For more information, please visit Venrock’s website at www.venrock.com.